Trial Condition(s):
Evaluating the efficacy and safety of vardenafil in subjects with erectile dysfunction and hypertension
Assess efficacy of Vardenafil in patients erectile dysfunction and high blood pressure
- Men >/= 18 years of age, with 6 months or longer diagnosis of ED as defined by NIH Consensus statement, - Arterial hypertension adequately controlled - Stable sexual relationship for > 6 month
- Primary hypoactive sexual desire - History of myocardial infarction, stroke or life-threatening arrhythmia within prior 6 month - Nitrate therapy
Locations | Status |
---|
A randomized, double-blind, parallel-group, plac-controlled study evaluating the efficacy and safety of vardenafil administration for 12 weeks in a flexible-dose regimen compared to placebo in men with arterial hypertension and erectile dysfunction
Trial Type:
Interventional
Intervention Type:
Drug
Trial Purpose:
Treatment
Allocation:
Randomized
Blinding:
Double Blind
Assignment:
Parallel Assignment
Trial Arms:
2